{{Rsnum
|rsid=17119280
|Gene=FGGY
|Chromosome=1
|position=59333489
|Orientation=plus
|GMAF=0.0225
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FGGY
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 1.5 | 98.5
| JPT | 0.0 | 1.8 | 98.2
| YRI | 2.0 | 16.3 | 81.6
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.0 | 1.5 | 98.5
| CHD | 0.0 | 1.8 | 98.2
| GIH | 0.0 | 1.0 | 99.0
| LWK | 0.9 | 16.4 | 82.7
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 5.1 | 94.9
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=0.000007
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17119280
|overall_frequency_n=3
|overall_frequency_d=128
|overall_frequency=0.0234375
|n_genomes=2
|n_genomes_annotated=0
|n_haplomes=2
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}